Report Overview
The Global Cauti Prevention Urology Products Market size is expected to be worth around US$ 6.8 Billion by 2035 from US$ 3.2 Billion in 2025, growing at a CAGR of 7.9% during the forecast period 2026-2035. In 2025, North America led the market, achieving over 38.5% share with a revenue of US$ 1.2 Billion.
The CAUTI Prevention Urology Products Market focuses on medical devices and solutions designed to prevent catheter-associated urinary tract infections (CAUTIs), one of the most common healthcare-associated infections worldwide. These products include antimicrobial and hydrophilic urinary catheters, catheter securement devices, drainage bags, and infection prevention accessories used in hospitals, clinics, and long-term care facilities. The increasing prevalence of urinary disorders, growing number of surgical procedures, and rising use of indwelling urinary catheters are key factors driving market growth.
Healthcare organizations globally are emphasizing infection prevention strategies to reduce patient complications, hospital stays, and healthcare costs associated with CAUTIs. Regulatory agencies and healthcare providers are increasingly adopting evidence-based catheter management practices and advanced urology products to improve patient outcomes. Technological advancements such as antimicrobial coatings, silver-alloy catheters, and silicone-based materials are further enhancing product effectiveness and safety.
North America currently dominates the market due to advanced healthcare infrastructure and strict infection control guidelines, while Asia-Pacific is expected to witness significant growth owing to improving healthcare access and rising awareness of hospital-acquired infections.
*Click here for more information: https://market.us/report/cauti-prevention-urology-products-market/
*
Key Takeaways
- In 2025, the CAUTI Prevention Urology Products Market generated revenue of US$ 3.2 Billion and is projected to reach US$ 6.8 Billion by 2035, expanding at a CAGR of 7.9% during the forecast period.
- By product, the market is segmented into antimicrobial & coated catheters, closed drainage systems, external catheters (condom/pouches), intermittent (in-and-out) catheters, catheter securement devices, bladder scanners, and others. Among these, closed drainage systems dominated the market, accounting for a 37.1% share in 2025.
- Based on application, the market is categorized into urinary incontinence management, acute surgical/perioperative care, benign prostatic hyperplasia (BPH) and obstructive urology, neurogenic bladder & spinal cord injury (SCI), and others. The urinary incontinence management segment held a leading market share of 62.1% in 2025.
- In terms of end use, the market is divided into hospitals, long-term care facilities, home care settings, ambulatory surgical centers (ASCs), and others. The hospitals segment emerged as the dominant category, capturing the largest revenue share of 54.6%.
- North America led the global CAUTI Prevention Urology Products Market in 2025, securing a 38.5% share of the overall market.
Key Market Segments
- By Product
- Antimicrobial & Coated Catheters
- Closed Drainage Systems
- External Catheters (Condom/Pouches)
- Intermittent (In-and-Out) Catheters
- Catheter Securement Devices
- Bladder Scanners
- Others
- By Application
- Urinary Incontinence Management
- Acute Surgical/Perioperative Care
- Benign Prostatic Hyperplasia (BPH) and Obstructive Urology
- Neurogenic Bladder & Spinal Cord Injury (SCI)
- Others
- By End Use
- Hospitals
- Long Term Care Facilities
- Home Care Setting
- Ambulatory Surgical Centers (ASCs)
- Others
Market Key Players
- BD (Becton, Dickinson and Company)
- B. Braun SE
- Coloplast
- Teleflex Incorporated
- Cook Medical
- Medtronic
- Hollister Incorporated
- ConvaTec Group PLC
- Boston Scientific Corporation
- Cardinal Health
- Merit Medical
- Medline Industries, LP.
- Poiesis Medical LLC
Market Dynamics
Driver
The increasing prevalence of catheter-associated urinary tract infections (CAUTIs) is a major driver of the CAUTI Prevention Urology Products Market. According to the U.S. Centers for Disease Control and Prevention (CDC), urinary tract infections account for more than 30% of healthcare-associated infections reported by acute care hospitals, and 75% of these are linked to urinary catheters. Approximately 15% to 25% of hospitalized patients receive urinary catheters during their stay, increasing the risk of infection. CAUTIs can prolong hospital stays, raise healthcare costs, and lead to severe complications such as sepsis. The CDC estimates that each additional CAUTI episode can significantly increase treatment expenses and patient morbidity. As healthcare systems prioritize infection prevention and patient safety, demand for antimicrobial catheters, securement devices, and closed drainage systems continues to rise. Furthermore, government agencies and healthcare organizations are implementing strict infection-control guidelines, encouraging hospitals to adopt advanced urology products designed to minimize catheter-related infections and improve clinical outcomes.
Trend
A significant trend in the CAUTI Prevention Urology Products Market is the growing adoption of advanced catheter technologies, including antimicrobial-coated and hydrophilic catheters. The CDC recommends evidence-based strategies to reduce CAUTI incidence, prompting healthcare providers to invest in innovative devices that lower infection risk. Silver-alloy coatings, antimicrobial materials, and silicone-based catheters are increasingly being used to inhibit bacterial colonization and biofilm formation. The U.S. Food and Drug Administration (FDA) has also supported innovation in medical devices that improve patient safety and reduce hospital-acquired infections. Digital monitoring technologies and smart catheter systems capable of tracking catheter duration are emerging trends that help healthcare providers minimize unnecessary catheter use. According to the World Health Organization (WHO), hundreds of millions of patients globally are affected by healthcare-associated infections annually, emphasizing the need for advanced prevention solutions. These technological advancements are improving patient outcomes, reducing hospital costs, and shaping the future of infection prevention in urological care.
Restraint
Despite growing demand, the CAUTI Prevention Urology Products Market faces challenges related to the high cost of advanced prevention devices and increasing concerns regarding antimicrobial resistance. Antimicrobial-coated catheters and specialized infection prevention products often carry higher prices than conventional devices, limiting adoption in cost-sensitive healthcare settings. According to the World Health Organization (WHO), antimicrobial resistance was associated with nearly 4.95 million deaths globally in 2019, highlighting the need for cautious use of antimicrobial technologies. Healthcare facilities, especially in low- and middle-income countries, may struggle to justify the higher upfront costs of premium products despite their long-term benefits. Additionally, concerns about the overuse of antimicrobial coatings and the potential development of resistant pathogens may affect product adoption. Variability in reimbursement policies and limited awareness in certain regions further restrict market growth. Addressing affordability and promoting evidence-based catheter management practices will be essential to ensuring broader access to CAUTI prevention solutions worldwide.
Opportunity
The growing emphasis on infection prevention and the increasing elderly population present substantial opportunities for the CAUTI Prevention Urology Products Market. According to the United Nations, the global population aged 65 years and older is projected to exceed 1.5 billion by 2050, significantly increasing demand for urinary catheterization and related care. Older adults are more susceptible to urinary disorders and prolonged catheter use, elevating the risk of CAUTIs. Government initiatives aimed at reducing healthcare-associated infections are also creating favorable conditions for market expansion. For example, the CDC’s National Healthcare Safety Network (NHSN) tracks CAUTI rates and promotes prevention strategies in healthcare facilities across the United States. Additionally, expanding healthcare infrastructure in emerging economies and increasing awareness of patient safety are expected to drive demand for advanced urology products. Manufacturers have opportunities to develop cost-effective, antimicrobial, and smart catheter technologies that improve patient outcomes while reducing infection rates and healthcare expenditures globally.
Conclusion
The global CAUTI Prevention Urology Products Market is poised for substantial growth, driven by increasing awareness of catheter-associated urinary tract infections (CAUTIs), rising healthcare expenditure, and the growing emphasis on patient safety and infection control. The market is projected to expand from US$ 3.2 Billion in 2025 to US$ 6.8 Billion by 2035, registering a CAGR of 7.9% during the forecast period. The widespread adoption of advanced products such as antimicrobial catheters, closed drainage systems, and catheter securement devices is improving clinical outcomes while reducing the burden of hospital-acquired infections. Hospitals remain the leading end users due to their high catheter utilization rates and strict infection prevention protocols. North America currently dominates the market, supported by advanced healthcare infrastructure and robust regulatory frameworks. Meanwhile, emerging economies are expected to create new growth opportunities as healthcare access expands and awareness of infection prevention increases. With ongoing technological advancements and growing investments in healthcare quality improvement, the CAUTI Prevention Urology Products Market is expected to play a critical role in enhancing patient care and reducing healthcare-associated infections worldwide.
Top comments (0)